Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes

Detalles Bibliográficos
Autores principales: Gill, Dipender, Burgess, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676614/
https://www.ncbi.nlm.nih.gov/pubmed/33079601
http://dx.doi.org/10.1161/CIRCGEN.120.003061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676614/
https://www.ncbi.nlm.nih.gov/pubmed/33079601
http://dx.doi.org/10.1161/CIRCGEN.120.003061

Ejemplares similares